Drug Type Small molecule drug |
Synonyms AVL-8168 |
Target |
Action inhibitors, agonists |
Mechanism GABRA5 inhibitors(Gamma-aminobutyric acid A receptor alpha-5 inhibitors), α7 receptor agonists(Neuronal acetylcholine receptor protein alpha-7 subunit agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cognition Disorders | Preclinical | United States | - |





